ITGAL, the counterreceptor-ligand of ICAM1, was expressed in immune cells surrounding the tumor cells, both in the periphery and central tumor, as well as in the tumor-associated TLS (Supplementary Figure S1). The gene discussed is ITGAL; the disease is neoplasm.